5-Benzothiazolecarboxylic Acid

Copper and copper alloys catalyse the autoxidation of hydrocarbon streams, accelerating sludge and varnish formation in turbine oils, hydraulic fluids, and fuel systems. In the absence of effective passivation, dissolved Cu⁺ ions cycle between oxidation states, decomposing hydroperoxides at rates measurable by PDSC induction time loss exceeding 40% (ASTM D6186). 5-Benzothiazolecarboxylic acid (5-BTCA) operates by forming a stable, charge-neutral 5-membered chelate ring between the thiazole nitrogen and the deprotonated carboxylate, preferentially blocking the Cu⁺/Cu²⁺ redox shuttle. The compound is added to Group II and Group III base stocks at a concentration window of 0.15–0.5 wt%, typically pre-dissolved at 60°C in a coupling solvent such as 2-ethylhexanol or diethylene glycol monobutyl ether. The additive response is benchmarked against ASTM D130-19 (copper strip corrosion) where a 1a classification must be maintained after 24 h at 100°C. Full-scale downstream blending involves inline dosing into the finished lubricant after the hydrofinishing step, with homogeneous dispersion confirmed by FTIR spectroscopy targeting the carbonyl stretch at 1,698 cm⁻¹. Field data from steam turbine electro-hydraulic control systems indicate that without 5-BTCA, varnish potential rating (ASTM D7843) escalates above 30 within 5,000 service hours; inclusion at 0.3 wt% stabilises the MPC ΔE value below 15 for intervals exceeding 12,000 h. The finished product types range from R&O inhibited circulating oils (ISO 6743-4 Type CKB) to combustion turbine lubricants meeting GEK 32568F and MIL-PRF-17331K specifications. Note that pre-drying of 5-BTCA is mandatory if ambient relative humidity exceeds 60%, as residual moisture promotes esterification with the solvent matrix during storage.

Operational boundary data indicate that 5-BTCA is incompatible with ashless dithiophosphate anti-wear additives unless a sacrificial amine buffer is introduced; otherwise, competitive ligation around the central zinc atom can destabilise the thiophosphate backbone, elevating the Four-Ball weld load variability (ASTM D2783) by ±12%.

What occurs when the C7 carboxylic acid moiety is activated as the acid chloride for heterocycle fusion?

The transformation of 5-benzothiazolecarboxylic acid into its acid chloride derivative using thionyl chloride at −5 °C to 0 °C in anhydrous dichloromethane forms the cornerstone of several antifungal and anti-infective API syntheses, particularly those requiring a benzothiazolo[5,4-b]pyridine or thiazolo[4,5-f]indazole scaffold. In this process, the molar feed ratio of 5-BTCA to thionyl chloride is maintained at 1.0 : 1.05–1.10 to ensure quantitative conversion with minimal sulfonic acid by-product. The exothermic evolution of HCl and SO₂ requires a glass-lined reactor (Pfaudler AE series) equipped with a low-temperature circulation system capable of maintaining jacket outlet temperature at −15 °C; gas scrubbing through a 10% NaOH packed column is mandatory under ICH Q7 Chapter 8 operational guidelines. Following 4 h ageing under nitrogen, the acyl chloride intermediate is directly reacted with an ortho-diamine or a substituted amidine in the same vessel at a rate-controlled addition keeping the internal temperature below +5 °C, forming the thiazine or imidazole junction. The product is precipitated by drowning in deionised water at ≤ 2 °C and isolated through a Nutsche filter-dryer, with residual thionyl chloride content verified below 10 ppm by headspace GC-MS. Recrystallisation from isopropanol–water (70:30 v/v) yields a polymorph with a DSC melting endotherm onset of 241.3 ± 0.6 °C, compliant with Ph. Eur. monograph specifications. Compliance framework includes ICH Q7 for GMP manufacturing, FDA 21 CFR 210/211 for finished dosage form tracing, and REACH Annex XVII for impurities management. The final drug substance types span triazole and benzimidazole antifungals, non-nucleoside reverse transcriptase inhibitors, and oral Janus kinase inhibitors, with typical active content ranging from 2.5 mg to 300 mg per tablet intermediate depending on the therapeutic index.

The fluorescence quantum yield of 5-benzothiazolecarboxylic acid derivatives exhibits a marked pH dependence, enabling ratiometric emission tuning between 485 nm and 576 nm upon deprotonation of the carboxyl group. This photophysical behaviour is exploited when the carboxylic acid is immobilised onto amine-functionalised hydrogel beads via an EDC/NHS-mediated amidation in MES buffer at pH 5.8, requiring a molar excess of 1.5 eq 5-BTCA relative to surface amine density. The resulting conjugate serves as a solid-state heavy-metal sensing probe, with a detection limit of 0.8 ppb for Hg²⁺ when excited at 370 nm (validated against ISO 11885 inductively coupled plasma optical emission spectrometry). In textile optical brightener synthesis, 5-BTCA is condensed with 2-aminothiophenol under high-temperature polyphosphoric acid conditions to generate bis(benzothiazolyl) stilbene-type agents; the mass fraction of the benzothiazole precursor in the condensation melt is typically controlled at 48–52% to avoid over-cyclisation. Downstream formulation into aqueous dispersion involves bead-milling to a particle size D₉₀ below 2.0 μm, with slurry stability maintained using ethoxylated fatty alcohol surfactants. The final brightener product complies with the ecological pass criteria of Oeko-Tex Standard 100 Appendix 4, and brands target home laundry detergent powders at incorporation levels of 0.07–0.12 wt% of the finished powder.

When titanium alkoxide complexes require a thermally robust chelating ligand for polycondensation catalysis

In antimony-free PET resin production lines, 5-benzothiazolecarboxylic acid functions as a bidentate ligand that moderates the catalytic activity of tetrabutyl titanate, preventing excessive transesterification and gel formation during the polycondensation phase. The ligand-to-titanium molar ratio is set at 2.0:1.0, forming a titanium-bis(benzothiazolecarboxylate) complex with an onset of thermal decomposition at 312 °C by TGA, well above the typical polycondensation temperature window of 275–295 °C. This complex is introduced into the oligomer melt after the esterification stage, targeting a residual titanium content in the final polymer of 15–45 ppm. The melt-phase processing takes place in a horizontal disc-ring reactor with a final vacuum stage of 80 ± 15 Pa, and intrinsic viscosity reaches 0.82–0.88 dL/g (determined in phenol/tetrachloroethane 60:40 at 25 °C per ASTM D4603) within 160 min residence time. Film-grade chips produced via this route exhibit colour L* value above 82 and b* below 0.5, measured with a HunterLab spectrophotometer using the CIE system. All materials intended for direct food contact are manufactured to comply with EU Regulation (EC) No 1935/2004 and the specific migration limits of EU 10/2011, with titanium migration below 1 mg/kg of food simulant. 5-BTCA itself must be verified free of chlorinated aromatic species by GC-ECD, as residual benzoyl chloride impurities interfere with the chelation stoichiometry and accelerate metal corrosion on the recycle glycol lines.

Acidic cupric chloride etching solutions used in high-density interconnect PCB fabrication encounter a side-etch dilemma when pattern pitches shrink below 30 μm. Adequate copper dissolution rates demand a free acid concentration of 1.8–2.4 mol/L HCl, yet at this acidity, the isotropic etch component routinely undercuts the tin or organic resist by 5–8 μm per side, violating the conductor width tolerance of ± 10% specified in IPC-6012C Class 3. Incorporating 5-benzothiazolecarboxylic acid as a dissolved micro-etch inhibitor at a bath loading of 0.15–1.0 g/L suppresses the sidewall attack rate while preserving the vertical etch rate above 35 μm/min at 48 °C. The compound adsorbs preferentially on the freshly exposed copper crystal planes, with Tafel polarisation data indicating an increase in charge transfer resistance from 180 Ω·cm² to 1,240 Ω·cm² in a 2 M HCl–0.5 M CuCl₂ model bath. Bath maintenance protocols recommend continuous replenishment via a dosing pump calibrated to 3.0 mL of a 5% w/v aqueous sodium salt solution per 1.0 kg of copper etched, compensating for drag-out and oxidative consumption. End-use printed circuit assemblies are qualified under IPC-6012C, with cross-sections examined by SEM at 2,500× magnification to confirm an undercut reduction to less than 2.0 μm per side. Published data for this specific inhibitor configuration in alkaline etch regimes is limited; current industrial practice confines its use to acidic chloride chemistries.

Thermoplastic elastomer surfaces with persistent contact bacteriostasis via salt-form metal complexation

5-Benzothiazolecarboxylic acid, when converted to its zinc(II) complex, acts as a non-leaching antibacterial additive for SEBS-based medical elastomers processed by twin-screw extrusion. The zinc salt is prepared off-line by reacting the acid with zinc acetate dihydrate in aqueous ethanol at 70 °C, followed by vacuum drying to a moisture content below 0.3 wt%. In the compounding stage, it is metered into the main feed throat of a co-rotating twin-screw extruder (L/D 44:1) along with the SEBS crumb and medical-grade white oil. The screw profile employs two kneading block sections to achieve a melt temperature of 195 ± 5 °C; the recommended incorporation level is 0.6–1.2 wt% of the total formulation. After underwater pelletising and injection moulding at a clamp force of 800 kN, plaques are tested according to ISO 22196:2011 against Staphylococcus aureus (ATCC 6538P) and Escherichia coli (ATCC 8739), yielding a logarithmic reduction of 3.1–4.8 log₁₀ at 24 h contact time. The additive’s migration resistance is verified through exhaustive extraction in saline and ethanol (ISO 10993-12) with the zinc ion release remaining under 2.0 μg/cm², allowing the compound to pass USP Class VI systemic injection and intracutaneous reactivity tests. Finished articles include respirator mask check valves, infusion pump keypads, and gasket seals for anaesthesia circuits, all of which retain antibacterial activity after 100 cycles of autoclave sterilisation at 121 °C. Processors must note that the zinc complex acts as a nucleating agent, raising the SEBS solidification onset by 6–8 °C; the cooling water temperature should be increased accordingly to avoid warpage.